Abe, J., Yamada, Y., Takeda, A., Harashima, H.(2018). Cardiac progenitor cells activated by mitochondrial delivery of resveratrol enhance the survival of a doxorubicin-induced cardiomyopathy mouse model via the mitochondrial activation of a damaged myocardium. J. Control. Release. 269, 177-188.
Alanazi, A., Fadda, L., Alhusaini, A., Ahmad, R. ( 2020a ) . Antioxidant, antiapoptotic, and antifibrotic effects of the combination of liposomal resveratrol and carvedilol against doxorubicin-induced cardiomyopathy in rats. J. Biochem. Mol. Toxicol. 34, e22492.
Alanazi, A.M., Fadda, L., Alhusaini, A., Ahmad, R., Hasan, I.H., Mahmoud, A.M.(2020b). Liposomal Resveratrol and/or Carvedilol Attenuate Doxorubicin-Induced Cardiotoxicity by Modulating Inflammation, Oxidative Stress and S100A1 in Rats. Antioxidants. (Basel). 9, 159.
Cheng, Y., Liu, D.Z., Zhang, C.X., Cui, H., Liu, M., Zhang, B.L., Mei, Q.B., Lu, Z.F., Zhou, S.Y. (2019). Mitochondria-targeted antioxidant delivery for precise treatment of myocardial ischemia-reperfusion injury through a multistage continuous targeted strategy. Nanomedicine. 16, 236-249.
Cheung, K.G., Cole, L.K., Xiang, B., Chen, K., Ma, X., Myal, Y., Hatch, G.M., Tong, Q., Dolinsky, V.W. ( 2015 ) . Sirtuin-3 (SIRT3) Protein Attenuates Doxorubicin-induced Oxidative Stress and Improves Mitochondrial Respiration in H9c2 Cardiomyocytes. J. Biol. Chem. 290, 10981-10993.
Dolinsky, V.W., Rogan, K.J., Sung, M.M., Zordoky, B.N., Haykowsky, M.J., Young, M.E., Jones, L.W., Dyck, J.R.(2013). Both aerobic exercise and resveratrol supplementation attenuate doxorubicin-induced cardiac injury in mice. Am. J. Physiol. Endocrinol. Metab. 305, E243-253.
Dranka, B.P., Hill, B.G., Darley-Usmar, V.M.(2010). Mitochondrial reserve capacity in endothelial cells: The impact of nitric oxide and reactive oxygen species. Free. Radic. Biol. Med. 48, 905-914.
Fan, C., Joshi, J., Li, F., Xu, B., Khan, M., Yang, J., Zhu, W. (2020). Nanoparticle-Mediated Drug Delivery for Treatment of Ischemic Heart Disease. Front. Bioeng. Biotechnol. 8, 687.
Gong, G., Liu, J., Liang, P., Guo, T., Hu, Q., Ochiai, K., Hou, M., Ye, Y., Wu, X., Mansoor, A., From, A.H., Ugurbil, K., Bache, R.J., Zhang, J.(2003). Oxidative capacity in failing hearts. Am. J. Physiol. Heart. Circ. Physiol. 285, H541-548.
Hausenloy, D.J., and Yellon, D.M. (2013). Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J. Clin. Invest. 123, 92-100.
Machado, N.D., Fernandez, M.A., Diaz, D.D. (2019). Recent Strategies in Resveratrol Delivery Systems. Chempluschem. 84, 951-973.
Pala, R., Anju, V.T., Dyavaiah, M., Busi, S., Nauli, S.M. (2020). Nanoparticle- Mediated Drug Delivery for the Treatment of Cardiovascular Diseases. Int. J. Nanomedicine. 15, 3741-3769.
Saludas, L., Pascual-Gil, S., Roli, F., Garbayo, E., Blanco-Prieto, M.J.(2018). Heart tissue repair and cardioprotection using drug delivery systems. Maturitas. 110, 1-9.
Satrialdi, Munechika, R., Biju, V., Takano, Y., Harashima, H., Yamada, Y.(2020). The optimization of cancer photodynamic therapy by utilization of a pi-extended porphyrintype photosensitizer in combination with MITO-Porter. Chem. Commun. (Camb). 56, 1145-1148.
Satrialdi, Takano, Y., Hirata, E., Ushijima, N., Harashima, H., Yamada, Y.(in press). The effective in vivo mitochondrial-targeting nanocarrier combined with a π-extended porphyrin-type photosensitizer. Nanoscale. Advances.
Schipper, D.A., Palsma, R., Marsh, K.M., O'Hare, C., Dicken, D.S., Lick, S., Kazui, T., Johnson, K., Smolenski, R.T., Duncker, D.J., Khalpey, Z.(2017). Chronic Myocardial Ischemia Leads to Loss of Maximal Oxygen Consumption and Complex I Dysfunction. Ann. Thorac. Surg. 104, 1298-1304.
Wanka, H., Lutze, P., Staar, D., Grunow, B., Peters, B.S., Peters, J.(2018). An alternative renin isoform is cardioprotective by modulating mitochondrial metabolism. J. Cell. Mol. Med. 22, 5991-6001.
Yamada, Y., Akita, H., Kamiya, H., Kogure, K., Yamamoto, T., Shinohara, Y., Yamashita, K., Kobayashi, H., Kikuchi, H., Harashima, H.(2008). MITO-Porter: A liposome-based carrier system for delivery of macromolecules into mitochondria via membrane fusion. Biochim. Biophys. Acta. 1778, 423-432.
Yamada, Y., Tabata, M., Yasuzaki, Y., Nomura, M., Shibata, A., Ibayashi, Y., Taniguchi, Y., Sasaki, S., Harashima, H. (2014). A nanocarrier system for the delivery of nucleic acids targeted to a pancreatic beta cell line. Biomaterials. 35, 6430-6438.
Yamada, Y., Daikuhara, S., Tamura, A., Nishida, K., Yui, N., Harashima, H.( 2019 ). Enhanced autophagy induction via the mitochondrial delivery of methylated β-cyclodextrin-threaded polyrotaxanes using a MITO-Porter. Chem. Commun. (Camb). 55, 7203-7206.
Yamada, Y., Ito, M., Arai, M., Hibino, M., Tsujioka, T., Harashima, H.(2020a). Challenges in Promoting Mitochondrial Transplantation Therapy. Int. J. Mol. Sci. 21, 6365.
Yamada, Y., Satrialdi, Hibino, M., Sasaki, D., Abe, J., Harashima, H.(2020b). Power of mitochondrial drug delivery systems to produce innovative nanomedicines. Adv. Drug. Deliv. Rev. 154-155, 187-209.
Yamada, Y., Somiya, K., Miyauchi, A., Osaka, H., Harashima, H.(2020c). Validation of a mitochondrial RNA therapeutic strategy using fibroblasts from a Leigh syndrome patient with a mutation in the mitochondrial ND3 gene. Sci. Rep. 10, 7511.
Yamada, Y., Fujishita, N., Harashima, H. (2020d). A nanocarrier for the mitochondrial delivery of nucleic acids to cardiomyocytes. Nucleosides. Nucleotides. Nucleic Acids. 39, 141-155.
Yamada, Y., Ishimaru, T., Ikeda, K., Harashima, H.(in press). Validation of the mitochondrial delivery of vitamin B1 to enhance ATP production using SH- SY5Y cells, a model neuroblast. J. Pharm. Sci.
Zhang, C.X., Cheng, Y., Liu, D.Z., Liu, M., Cui, H., Zhang, B.L., Mei, Q.B., Zhou, S.Y. (2019). Mitochondria-targeted cyclosporin A delivery system to treat myocardial ischemia reperfusion injury of rats. J. Nanobiotechnology. 17, 18.
Zhang, L., Zhu, K., Zeng, H., Zhang, J., Pu, Y., Wang, Z., Zhang, T., Wang, B.(2019). Resveratrol solid lipid nanoparticles to trigger credible inhibition of doxorubicin cardiotoxicity. Int. J. Nanomedicine. 14, 6061-6071.
タカラバイオ株式会社.(n.d.).Premix WST-1 Cell Proliferation Assay System 説明書.https://catalog.takara-bio.co.jp/PDFS/mk400_j.pdf.アクセス日:2021 年 10 月 9 日.